Cell Death, Cancer and Inflammation
Research in the Henning Walczak Laboratory is focused on cell death and ubiquitin in inflammation, cancer and immunity.

Chair: Cell Death, Cancer and Inflammation Research Group
UCL Cancer Institute
Research focus
Research in the Walczak Laboratory is focused on cell death and ubiquitin in inflammation, cancer and immunity. The lab is particularly interested in unravelling the mechanisms on how different death receptor-ligand systems such as the TNF, Fas (CD95) and TRAIL systems are regulated and how they impact cancer cell survival, cancer-related inflammation and immunity. The research aims are to develop novel cancer therapies by specifically inducing cancer cell death and by therapeutically directing the type of death induced in cancer cells to convert cancer-related inflammation from being immune-regulatory to enabling the immune system to recognise and kill cancer cells.

Fig.1 Human cancer cells undergoing TRAIL-induced cell death.
Selected publications
- Annibaldi A, Walczak H. Death Receptors and Their Ligands in Inflammatory Disease and Cancer. Cold Spring Harb Perspect Biol. 2020 Sep 1;12(9): a036384.
- Peltzer N, Walczak H. Cell Death and Inflammation - A Vital but Dangerous Liaison. Trends Immunol. 2019 May;40(5): 387-402.
- Lafont E, Draber P, Rieser E ... Walczak H. TBK1 and IKKε prevent TNF-induced cell death by RIPK1 phosphorylation. Nat Cell Biol. 2018 Dec;20(12): 1389-1399.
- Taraborrelli L, Peltzer N, Montinaro A ... Walczak H. LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L. Nat Commun. 2018 Sep 25;9(1): 3910.
- Peltzer N, Darding M, Montinaro A ... Walczak H. LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis. Nature. 2018 May;557(7703): 112-117.
- von Karstedt S, Montinaro A, Walczak H. Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy. Nat Rev Cancer. 2017 May 24;17(6): 352-366.
- von Karstedt S, Conti A, Nobis M ... Walczak H. Cancer cell-autonomous TRAIL-R signaling promotes KRAS-driven cancer progression, invasion, and metastasis. Cancer Cell. 2015 Apr 13;27(4): 561-73.
Professorship Awards 2019
In a human adult, billions of cells kill themselves off every day. Programmed cell death is a self-protective mechanism: it is triggered, for example, when cells are irreparably damaged. Normally, the body then produces new cells so that there is a balance between cell death and cell propagation. Disturbances in these mechanisms are thought to be a crucial factor in the development of cancer and autoimmune diseases. This is where the research of biochemist and cancer researcher Henning Walczak comes in.
Features

New drug target could control onset of neurodegenerative and inflammatory diseases
We have discovered a new checkpoint that prevents a certain type of cell death from occurring. This could help us further understand the progression of autoimmune and neurodegenerative diseases.

Body's defences hijacked to make cancers more aggressive
UCL scientists have discovered that a vital self-destruct switch in cells is hijacked - making some pancreatic and non small cell lung cancers more aggressive.

Scientists trigger self-destruct switch in lung cancer cells
Cancer Research UK scientists have found a drug combination that can trigger the self-destruct process in lung cancer cells - paving the way for new treatments, according to new research.
Contact
UCL Cancer Institute
Room 416, Paul O'Gorman Building
72 Huntley Street
London, WC1E 6BT

Professor Henning Walczak, PhD
Chair: Cell Death, Cancer and Inflammation Research Group
Click to email. h.walczak@ucl.ac.uk Click to call. +44 207 679 6471